Table 1.

Fetal and maternal serum measurements

Serum Measurements	SC (Mean ± SEM)	RNAi-IUGR (Mean ± SEM)	P value (SC vs RNAi-IUGR)	RNAi-NW (Mean ± SEM)	P value (SC vs RNAi-NW)
UtA insulin (ng/ml)	0.40 ± 0.08	0.94 ± 0.31	0.14	0.40 ± 0.10	0.99
UtA gluocse (mmol/L)	3.39 ± 0.56	3.70 ± 0.54	0.69	3.05 ± 0.16	0.54
UtA insulin:glucose	0.12 ± 0.02	0.24 ± 0.06	0.08	0.13 ± 0.03	0.78
UmbA insulin (ng/ml)	0.56 ± 0.13	0.29 ± 0.06	0.07	0.36 ± 0.04	0.15
UmbA glucose (mmol/L)	0.80 ± 0.31	0.53 ± 0.21	0.48	0.61 ± 0.11	0.57
UmbA insulin:glucose	1.21 ± 0.27	1.77 ± 0.78	0.51	0.62 ± 0.11	0.08
UtV glucose (mmol/L)	3.06 ± 0.50	3.34 ± 0.56	0.71	2.64 ± 0.17	0.43
UtA-UtV glucose(mmol/L)	0.23 ± 0.04	0.36 ± 0.03	0.02	0.42 ± 0.06	0.02
UmbV Glucose (mmol/L)	0.97 ± 0.33	0.77 ± 0.22	0.62	0.76 ± 0.10	0.56
UmbV-UmbA glucose (mmol/L)	0.17 ± 0.04	0.24 ± 0.07	0.42	0.15 ± 0.03	0.66

Serum concentrations are mean ± SEM. UtA, uterine artery; UtV, uterine vein; UmbA, umbilical artery; UmbV, umbilical vein. SC and RNAi-IUGR data in this table were previously presented (Baker et al. 2016) and is incorporated here to build a comparison. (n=8/treatment). P ≤ 0.10 indicates a trending difference from controls. P ≤ 0.05 indicates a significant difference from controls.